Kenechukwu, Franklin Chimaobi
Nnamani, Daniel Okwudili
Nmesirionye, Bright Ugochukwu
Isaac, God’spower Tochukwu
Momoh, Mumuni Audu
Attama, Anthony Amaechi
Funding for this research was provided by:
Tertiary Education Trust Fund (Grant no. TETFUND/DR&D/CE/NRF/2019/STI/46/)
Article History
Accepted: 28 April 2022
First Online: 12 May 2022
Declarations
:
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All experimental protocols were conducted with strict adherence to the guidelines of the Institutional Animal Care and Use Committee of the University of Nigeria, Nsukka. Ethical clearance approval for in vivo antidiabetic studies was sought and obtained from the Faculty of Pharmaceutical Sciences Research Ethics Committee (UNN/FPS/2019-2020_017X) before the commencement of the in vivo animal studies.
: The authors declare that they have no conflicts of interest.